This study demonstrated that a coding-change genetic variation in the gene encoding MAVS has a functional impact on the antiviral IFN pathway in humans, and is associated with a serologic subgroup of SLE patients (Pothlichet et al., 2011). Here, IFNA1 is linked to systemic lupus erythematosus.